Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ELAN
ELANCO ANIMAL HEALTH INCORPORATED
NYSE
$24.11
▼ DOWN 1.55% (-0.38)

KEY STATISTICS

Market Cap$12.04 B
52w High$27.98
52w Low$17.11
Dividend Yield—
Frequency—
P/E22.75
Volume4.17M
Shares Out.499.45M

COMPANY

LEADERSHIP

Jeffrey N. Simmons
CHIEF EXECUTIVE
Jeffrey N. Simmons

COMPENSATION 2026

Salary$0
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$0

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 20, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
9,650

PRICE TARGET

Target High$30.00
Target Low$26.00
Target Median$28.00
Target Consensus$28.00

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$1.21B
NOV
4
WED

PRICE

$24.11 ▼ DOWN 1.55% (−$0.38)
$24.00$24.20$24.40$24.609:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM24.11

About Elanco Animal Health Incorporated

https://www.elanco.com ↗

Elanco Animal Health develops and markets products for pets and farm animals, including vaccines, therapeutics, parasiticides, and nutritional products, serving veterinarians, distributors, and producers worldwide.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT ELANCO ANIMAL HEALTH INCORPORATED IS KNOWN FOR

Credelio Quattro
Credelio Quattro

Launched in 2025, this broad-spectrum oral parasiticide for dogs quickly became a blockbuster, protecting against fleas, ticks, heartworm, and intestinal worms, and is now a key growth driver in the company's pet health portfolio.

COMPETITORS

COMPETITOR
IDXX COMPARE
MRK COMPARE
PAHC COMPARE
ZTS COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Pet Health$533M $489M ▼$710M ▲$718M ▲
Farm Animal$593M $640M ▲$642M ▲$633M ▼
Cattle$289M $296M ▲$316M ▲$313M ▼
Poultry$217M $237M ▲$230M ▼$223M ▼
Swine$87M $107M ▲$96M ▼$97M ▲
Contract Manufacturing$11M $15M ▲$19M ▲$17M ▼

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
NonUS$590M $604M ▲$766M ▲$705M ▼
UNITED STATES$547M $540M ▼$605M ▲$663M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
228
LISTED HERE
26
RANKED BY POSITION SIZE
XMH.TO
0.34% · 17.5M
VTS.AX
0.02% · 15.9M
XMMO
1.45% · 4.4M
MDY
0.34% · 3.7M
DFAT
0.46% · 2.8M
SCHM
0.22% · 1.4M
FMDE
0.21% · 707.6K
CGMM
0.40% · 620.0K
MOO
1.40% · 592.4K
TSME
1.25% · 462.5K
JHMM
0.18% · 434.9K
FTXH
0.76% · 329.3K
NUSC
0.49% · 287.7K
USVM
0.29% · 215.7K
BBMC
0.24% · 214.4K
BSMC
2.38% · 180.8K
TMSL
0.13% · 158.8K
WSCSRI.SW
0.46% · 154.5K
PB
PBPH
0.27% · 114.9K
AVUS
0.02% · 91.6K
EZM
0.24% · 90.6K
BKMC
0.30% · 81.8K
VETS
1.01% · 75.7K
IQSM
0.44% · 62.8K
ZUH.TO
1.11% · 61.7K
XHYH
0.62% · 48.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
87.72%
HOLDERS
727
TOP 12 OF 727 · RANKED BY POSITION SIZE
Dodge & Cox
82.8M sh · $1.67B
Fmr LLC
65.4M sh · $1.32B
Primecap Management Co/Ca/
50.0M sh · $1.01B
Blackrock, Inc.
48.8M sh · $1.2B
Vanguard Group Inc
48.6M sh · $978.54M
T. Rowe Price Investment Management, Inc.
34.6M sh · $828.82M
Dimensional Fund Advisors LP
25.4M sh · $625.53M
Blackrock Inc.
23.3M sh · $336.24M
Ubs Group AG
16.5M sh · $331.67M
State Street Corp
16.1M sh · $395.31M
Winslow Capital Management, LLC
13.6M sh · $325.79M
Amundi Asset Management Us, Inc.
13.1M sh · $385.42M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book3
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Sale
2025-10-27
 Valerie Hoyle
Valerie Hoyle
Sale (Full)
2025-09-23
 Val Hoyle
Val Hoyle
Sale
2025-09-23
 Daniel Goldman
Daniel Goldman
Sale (Partial)
2023-03-06

INSIDER TRADES

★
OFFICER: SEE REMARKS
Modi Rajeev A.
Purchase · 61 shares
2026-08-21
★
OFFICER: EVP AND CFO
VanHimbergen Robert M
Purchase · 8 shares
2026-08-21
★
DIRECTOR, OFFICER: PRESIDENT, CEO AND DIRECTOR
Simmons Jeffrey N
Purchase · 117 shares
2026-08-21
★
DIRECTOR
Kurzius Lawrence Erik
Purchase · 40.0K shares
2026-08-20

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
OVERWEIGHT 3
EQUAL WEIGHT 1
OUTPERFORM 1
9 GRADES IN THE LAST 12 MONTHS
Keybanc OVERWEIGHT UBS BUY Morgan Stanley EQUAL WEIGHT TD Cowen BUY JP Morgan OVERWEIGHT Citigroup BUY Leerink Partners OUTPERFORM Piper Sandler OVERWEIGHT

SECTORS PEERS

PEERPRICE
RVMD$207.88COMPARE
VTRS$16.34COMPARE
SOLV$91.12COMPARE
NBIX$154.06COMPARE
RVTY$128.80COMPARE
EHC$120.85COMPARE
ALGN$157.58COMPARE
RDY$12.18COMPARE